From Our Medical Advisory Board
Many of the Members of our Medical Advisory Board work as clinicians for MOG-AD patients in addition to their involvement in important research to further understanding of this relatively new disease which has an ever-changing landscape. Their work is often exploring a new frontier. We are pleased to provide a series of pages designed to highlight the important research publications and clinical trials by each center of of MOG-AD research. These publications are supplied with full permission from the experts on our Medical Advisory Board.
Dr. John Chen, Dr. Sean Pittock, and Dr. Eoin Flanagan support our mission by providing their latest research publications from The Mayo Clinic Neuroimmunology Laboratory, where remarkable work in research for of MOG-AD has been performed. Their work in the area of MOG-AD has made a huge impact in recent years. Our community is lucky to benefit from the resources presented by these experienced researchers and clinicians.
Dr. Michael Levy is the head of The NMO Clinic and Research Laboratory at Massachusetts General Hospital. His research in Neuromyelitis Optica (NMO) and Transverse Myelitis (TM) is globally recognized. As he expands his research in the areas of rare neuroimmune disorders, MOG-AD patients are now the recipient of his expertise as part of his MOG Initiative.